Antifungal Activity of Phlorotannins against Dermatophytes and Yeasts: Approaches to the Mechanism of Action and Influence on Candida albicans Virulence Factor

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Lopes, Graciliana ^a   Pinto, Eugénia ^a   Andrade, Paula B ^a   Valentão, Patrícia ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHITIN; ERGOSTEROL; FUNGAL EXTRACT; OXIDOREDUCTASE; PHLOROTANNIN; RHODAMINE 123; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; CANDIDA ALBICANS; CANDIDA NODICAULIS; CANDIDA USNEOIDES; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EPIDERMOPHYTON FLOCCOSUM; FUCUS SPIRALIS; FUNGAL MEMBRANE; FUNGAL VIRULENCE; FUNGUS HYPHAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOHYPHAE; RESPIRATORY CHAIN; SEAWEED; TRICHOPHYTON RUBRUM; YEAST; YEAST CELL;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CANDIDA ALBICANS; CELL MEMBRANE; HUMANS; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIA; PLANT EXTRACTS; SEAWEED; TANNINS; VIRULENCE FACTORS; YEASTS;

EID: 84881492263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072203     Document Type: Article

References (35)

1. Richardson MD, Warnock DW (2012) In: Fungal infection: diagnosis and management. 4rd ed, Wiley-Blackwell, Oxford, UK.
2. Ghannoum MA, Rice LB, (1999) Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517.
3. Thomas NV, Kim SK, (2011) Potential pharmacological applications of polyphenolic derivatives from marine brown algae. Environ Toxicol Phar 32: 325-335.
4. Hector RF, (1993) Compounds active against cell walls of medically important fungi. Clin Microbiol Rev 6: 1-21.
5. Martins VP, Dinamarco TM, Curti C, Uyemura SA, (2011) Classical and alternative components of the mitochondrial respiratory chain in pathogenic fungi as potential therapeutic targets. J Bioenerg Biomembr 43: 81-88.
6. Mitchell AP, (1998) Dimorphism and virulence in Candida albicans. Curr Opin Microbiol 1: 687-692.
7. Carrillo-Muñoz AJ, Quindós G, Cárdenes CD, Alonso-Vargas R, Brió S, et al. (2003) Performance of Bacticard™ Candida compared with the germ tube test for the presumptive identification of Candida albicans. Biofactors 46: 467-470.
8. Ruy F, Vercesi AE, Kowaltowski AJ, (2006) Inhibition of specific electron transport pathways leads to oxidative stress and decreased Candida albicans proliferation. J Bioenerg Biomembr 38: 129-135.
9. Kumar V, Abbas AK, Aster JC (2013) Cell injury, cell death and adaptations. In: Kumar V, Abbas AK, Aster JC, Robbins Basic Pathology. Philadelphia: Elsevier Saunders. 1-28.
10. Chapman SW, Cleary JD, Rogers PD (2003) Systemic antifungal drugs: Amphotericin B. In: Dismukes WE, Pappas PG, Sobel JD editors. Clinical mycology, Oxford, USA: University Press. 33-48.
11. Como J, Dismukes W (2003) Systemic antifungal drugs: Azole antifungal drugs, 64-87. In Dismukes WE, Pappas PG, Sobel JD, Clinical mycology, Oxford University Press, USA.
12. Lopes G, Sousa C, Silva LR, Pinto E, Andrade PB, et al. (2012) Can phlorotannins purified extracts constitute a novel pharmacological alternative for microbial infections with associated inflammatory conditions? PloS ONE 7: e31145 doi:10.1371/journal.pone.0031145.
13. Lee MH, Lee KB, Oh SM, Lee BH, Chee HY, (2010) Antifungal activities of dieckol isolated from the marine brown alga Ecklonia cava against Trichophyton rubrum. J Korean Soc Appl Biol Chem 53: 504-507.
14. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard, 3rd ed; M27-A3; Wayne, PA, 2008a and Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard, 2nd ed; M38-A2; Wayne, PA, 2008b.
15. Pinto E, Queiroz MJRP, Vale-Silva LA, Oliveira JF, Begouin A, et al. (2008) Antifungal activity of synthetic di(hetero)arylamines based on the benzo[b]thiophene moiety. Bioorg Med Chem 16: 8172-8177.
16. Lima-Neto RG, Beltrão EIC, Oliveira PC, Neves RP, (2009) Adherence of Candida albicans and Candida parapsilosis to epithelial cells correlates with fungal cell surface carbohydrates. Mycosis 54: 23-29.
17. Pinto E, Afonso C, Duarte S, Vale-Silva L, Costa E, et al. (2011) Antifungal activity of xanthones: Evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography. Chem Biol Drug Des 77: 212-222.
18. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ, (1999) Quantification of ergosterol content: Novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37: 3332-3337.
19. Lopes G, Sousa C, Bernardo J, Andrade PB, Valentão P, et al. (2011) Sterol profiles in 18 macroalgae of the portuguese coast. J Phycol 47: 1210-1218.
20. Fortwendel JR, Juvvadi PR, Pinchai N, Perfect BZ, Alspaugh JA, et al. (2009) Differential effects of inhibiting chitin and 1,3-β-D-glucan synthesis in RAS and calcineurin mutants of Aspergillus fumigatus. Antimicrob Agents Chemother 53: 476-482.
21. Ludovico P, Sansonetty F, Côrte-Real M, (2001) Assessment of mitochondria membrane potential in yeast cell populations by flow cytometry. Microbiology 147: 3335-3343.
22. Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, et al. (2006) Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob Agents Chemother 50: 3312-3316.
23. Valentin E, Mormeneo S, Sentandreu R (2000) The cell surface of Candida albicans during morfogenesis. In: Ernst JF, Schmidt A Dimorphism in human pathogenic and apathogenic yeast. Switzerland: Karger. 138-150.
24. Rosenfeld E, Beauvoit B, (2003) Role of the non-respiratory pathways in the utilization of molecular oxygen by Saccharomyces cerevisiae. Yeast 20: 1115-1144.
25. Meletiadis J, Meis JFGM, Mouton JW, Donnelly JP, Verweij PE, (2000) Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol 38: 2949-2954.
26. Fernández-Checa JC, García-Ruiz C, Colell A, Morales A, Marí M, et al. (1998) Oxidative stress: Role of mitochondria and protection by glutathione. Biofactors 8: 7-11.
27. Lemasters JJ, Nieminen AL, Quian T, Trost LC, Herman B, (1997) The mitochondrial permeability transition toxic, hypoxic and reperfusion injury. Mol Cell Biochem 174: 159-165.
28. Pinton P, Brini M, Bastianutto C, Tuft RA, Pozzan T, et al. (1998) New light on mitochondrial calcium. Biofactors 8: 243-253.
29. Gerencser AA, Chinopoulos C, Birket MJ, Jastroch M, Vitelli C, et al. (2012) Quantitative measurement of mitochondrial membrane potential in cultured cells: calcium-induced de- and hyperpolarization of neuronal mitochondria. J Physiol 590: 2845-2871.
30. Vander-Heiden MGV, Thompson CB, (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1: 209-216.
31. Hamann A, Brust D, Osiewacz HD, (2008) Apoptosis pathways in fungal growth, development and ageing. Trends Microbiol 16: 276-283.
32. Cao J, Liu Y, Jia L, Zhou HM, Kong Y, et al. (2007) Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radical Bio Med 43: 968-975.
33. Green DR, Reed JC, (1998) Mitochondria and apoptosis. Apoptosis 281: 1309-1312.
34. Moon EH, Islam MN, Ahn BR, Chowdhuri SS, Sohn HS, et al. (2011) Protein tyrosine phosphatase 1B and α-glucosidase inhibitory phlorotannins from edible brown algae, Ecklonia stolonifera and Ecklonia bicyclis. Biosci Biotechnol Biochem 75: 1472-1480.
35. Bramono K, Yamazaki M, Tsuboi R, Ogawa H, (2006) Comparison of proteinase, lipase and alpha-glucosidase activities from the clinical isolates of Candida species. Jpn J Infect Dis 59: 73-76.